These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 21242512

  • 1. IL-3 attenuates collagen-induced arthritis by modulating the development of Foxp3+ regulatory T cells.
    Srivastava RK, Tomar GB, Barhanpurkar AP, Gupta N, Pote ST, Mishra GC, Wani MR.
    J Immunol; 2011 Feb 15; 186(4):2262-72. PubMed ID: 21242512
    [Abstract] [Full Text] [Related]

  • 2. Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3(+) regulatory and IL-17(+) pathogenic T cell in autoimmune arthritis.
    Park MK, Park JS, Cho ML, Oh HJ, Heo YJ, Woo YJ, Heo YM, Park MJ, Park HS, Park SH, Kim HY, Min JK.
    Immunol Lett; 2011 Mar 30; 135(1-2):50-8. PubMed ID: 20933009
    [Abstract] [Full Text] [Related]

  • 3. Treatment of collagen-induced arthritis by Natura-alpha via regulation of Th-1/Th-17 responses.
    Glatigny S, Blaton MA, Mencher SK, Mistou S, Lucas B, Fournier C, Wang LG, Chiocchia G.
    Eur J Immunol; 2010 Feb 30; 40(2):460-9. PubMed ID: 20077403
    [Abstract] [Full Text] [Related]

  • 4. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Arthritis Rheum; 2009 Apr 30; 60(4):1006-19. PubMed ID: 19333946
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM, Cornelissen F, Asmawidjaja PS, van Hamburg JP, Boon L, Hendriks RW, Lubberts E.
    Arthritis Rheum; 2010 Apr 30; 62(4):1043-50. PubMed ID: 20131264
    [Abstract] [Full Text] [Related]

  • 6. Regulatory T cells protect from local and systemic bone destruction in arthritis.
    Zaiss MM, Frey B, Hess A, Zwerina J, Luther J, Nimmerjahn F, Engelke K, Kollias G, Hünig T, Schett G, David JP.
    J Immunol; 2010 Jun 15; 184(12):7238-46. PubMed ID: 20483756
    [Abstract] [Full Text] [Related]

  • 7. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
    Lu Y, Xiao J, Wu ZW, Wang ZM, Hu J, Fu HZ, Chen YY, Qian RQ.
    Phytomedicine; 2012 Jul 15; 19(10):882-9. PubMed ID: 22673798
    [Abstract] [Full Text] [Related]

  • 8. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis.
    Notley CA, McCann FE, Inglis JJ, Williams RO.
    Arthritis Rheum; 2010 Jan 15; 62(1):171-8. PubMed ID: 20039431
    [Abstract] [Full Text] [Related]

  • 9. Comment on "IL-3 attenuates collagen-induced arthritis by modulating the development of Foxp3+ regulatory T cells".
    Wu XM, Zhu SX, Zhu WM, Zhang Y.
    J Immunol; 2011 Aug 01; 187(3):1071; author reply 1071-2. PubMed ID: 21772032
    [No Abstract] [Full Text] [Related]

  • 10. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, Aono H, Ishihara K, Huseby E, Betz UA, Murakami M, Hirano T.
    Int Immunol; 2007 Jun 01; 19(6):695-702. PubMed ID: 17493959
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, Ohsugi Y, Nishikawa T, Ripley B, Kimura A, Kishimoto T, Naka T.
    Arthritis Rheum; 2008 Dec 01; 58(12):3710-9. PubMed ID: 19035481
    [Abstract] [Full Text] [Related]

  • 12. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
    Woods AM, Thompson SJ, Wooley PH, Panayi G, Klavinskis LS.
    Arthritis Rheum; 2005 Dec 01; 52(12):3761-71. PubMed ID: 16329091
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis.
    Park MJ, Park HS, Cho ML, Oh HJ, Cho YG, Min SY, Chung BH, Lee JW, Kim HY, Cho SG.
    Arthritis Rheum; 2011 Jun 01; 63(6):1668-80. PubMed ID: 21384335
    [Abstract] [Full Text] [Related]

  • 14. Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis.
    Biton J, Semerano L, Delavallée L, Lemeiter D, Laborie M, Grouard-Vogel G, Boissier MC, Bessis N.
    J Immunol; 2011 Apr 01; 186(7):3899-910. PubMed ID: 21346237
    [Abstract] [Full Text] [Related]

  • 15. Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells.
    Jang E, Cho WS, Cho ML, Park HJ, Oh HJ, Kang SM, Paik DJ, Youn J.
    J Immunol; 2011 Feb 01; 186(3):1546-53. PubMed ID: 21209284
    [Abstract] [Full Text] [Related]

  • 16. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
    Kelchtermans H, Geboes L, Mitera T, Huskens D, Leclercq G, Matthys P.
    Ann Rheum Dis; 2009 May 01; 68(5):744-50. PubMed ID: 18480308
    [Abstract] [Full Text] [Related]

  • 17. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients.
    Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM, Cho ML, Kwok SK, Ju JH, Park KS, Cho SG, Park SH, Kim HY, Min JK.
    Immunol Lett; 2010 Jan 04; 127(2):150-6. PubMed ID: 19895848
    [Abstract] [Full Text] [Related]

  • 18. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology.
    Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY.
    J Immunol; 1998 Jun 01; 160(11):5654-60. PubMed ID: 9605172
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M.
    Arthritis Rheum; 2006 Mar 01; 54(3):864-76. PubMed ID: 16508968
    [Abstract] [Full Text] [Related]

  • 20. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
    Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O.
    Eur J Immunol; 1997 Jun 01; 27(6):1451-8. PubMed ID: 9209498
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.